In the News
Universal HDV screening in patients with HBV appears cost-effective
Compared with status quo screening rates, universal hepatitis D virus (HDV) testing of adults with chronic hepatitis B virus (HBV) infection could avert 100 HDV-related deaths, an additional 30 cases of cirrhosis, and 50 cases of hepatocellular carcinoma per 100,000 people screened, according to a modeling study.
Patient navigation improves colonoscopy completion at 1 year, study finds
Rates of follow-up colonoscopy in a U.S. study were higher in patients assigned to receive telephone-based navigation after an abnormal stool test versus usual care.
Study supports bariatric surgery in patients with obesity and cirrhosis
An economic evaluation of Veterans Health Administration data found that bariatric surgery was cost-effective among patients with cirrhosis at a willingness-to-pay threshold of $100,000 per quality-adjusted life-year.
MKSAP Quiz: 9-month history of intermittent abdominal pain, diarrhea
A 32-year-old man is evaluated for a 9-month history of intermittent abdominal pain and diarrhea. He reports no hematochezia, melena, or weight loss. Following a physical exam and lab studies, what is the most appropriate next step in management?
Spotlight on MASLD
Recent studies offered recommendations and evidence on screening for metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis, as well as using medications to reduce the risk of progression.
Update looks at gastroenterology/hepatology research from 2024
Topics include screening for colorectal cancer and treatment options for metabolic dysfunction-associated steatotic liver disease, among others.
Case reports cover disorders of the gallbladder
One describes sarcoidosis of the gallbladder wall and another details gallbladder ascariasis.
Choices in C. diff care
An infectious diseases expert gave an overview of the latest drugs and diagnostics at Internal Medicine Meeting 2025.
Gastric bypass increased diabetes remission versus sleeve gastrectomy, small trial finds
At five years after gastric bypass, half of patients with type 2 diabetes and obesity had an HbA1c level less than 6%, compared to 20% of those randomized to sleeve gastrectomy, according to a secondary analysis of a Norwegian trial.